Palatin Technologies, Inc. (OTCMKTS:PTNT – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $22.90 and traded as high as $24.15. Palatin Technologies shares last traded at $24.15, with a volume of 12 shares.
Palatin Technologies Stock Performance
The stock has a market capitalization of $966,000.00, a price-to-earnings ratio of -15.58 and a beta of 1.47. The company has a fifty day simple moving average of $24.43 and a two-hundred day simple moving average of $22.90.
Palatin Technologies Company Profile
Palatin Technologies, Inc is a biopharmaceutical company focused on developing medicines that target melanocortin receptors, a group of receptors involved in regulating appetite, sexual function, inflammation, and other physiological processes. The company’s research programs are intended to address conditions in areas such as obesity, sexual dysfunction, inflammatory disease, and related disorders.
Palatin’s best-known product is Vyleesi (bremelanotide), a melanocortin receptor agonist approved by the U.S.
Further Reading
- Five stocks we like better than Palatin Technologies
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
